Name :
HIF1a antibody
Documents :
DataSheet Material Safety Data Sheets (MSDS)
Description :
HIF1a Rabbit Polyclonal antibody. Positive WB detected in Cobalt Chloride treated HeLa cells, HeLa cells, mouse small intestine tissue. Positive IF detected in Hela cells. Positive IHC detected in human thyroid cancer tissue, human heart tissue, human kidney tissue. Positive FC detected in HeLa cells. Observed molecular weight by Western-blot: 120 kDa
Tested applications :
ELISA, IHC, IF, FC, WB
Species reactivity :
Human,Mouse,Rat; other species not tested.
Alternative names :
ARNT interacting protein antibody; bHLHe78 antibody; HIF 1 alpha antibody; HIF 1alpha antibody; HIF1 antibody; HIF1 ALPHA antibody; HIF1A antibody; Member of PAS protein 1 antibody; MOP1 antibody; PASD8 antibody
Immunogen :
Human HIF1a Recombinant protein (GST tag)
Isotype :
Rabbit IgG
Preparation :
This antibody was obtained by immunization of HIF1a recombinant protein (Accession Number: NM_001530). Purification method: Antigen affinity purified.
Clonality :
Polyclonal
Formulation :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage instructions :
Store at -20℃. DO NOT ALIQUOT
Applications :
Recommended Dilution: WB: 1:200-1:1000IHC: 1:20-1:200IF: 1:10-1:100
Background :
HIF1, the major regulator of the cellular responses to hypoxia, consists of an oxygen-sensitive subunit, HIF1alpha (HIFA), and an oxygen-insensitive subunit, HIF1beta (arylhydrocarbon receptor nuclear transporter [ARNT]). Although the mRNA is constitutively and ubiquitously expressed and transcribed, the HIF1A protein is rapidly degraded in the presence of oxygen. The half-life of HIF1A under ambient oxygeconditions is less than 5 min. Both hypoxic conditions and chemical hydroxylase inhibitors (such as desferrioxamine and cobalt) inhibit HIF-1α degradation and lead to its stabilization. In addition, HIF-1α can be induced in an oxygen-independent manner by various cytokines through the PI3K-AKT-mTOR pathway.
References :
Lin J, Qin X, Zhu Z. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β. IUBMB life. 64(11):921-30. 2012. Qu K, Yan Z, Wu Y. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma. Journal of gastroenterology and hepatology. 30(5):925-32. 2015. Hu T, He N, Yang Y, Yin C, Sang N, Yang Q. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas. Journal of experimental & clinical cancer research : CR. 34:22. 2015. Chen Z, Zhang Y, Jia C. mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression. Oncogene. 33(37):4548-57. 2014. Peng B, Liu F, Han R. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells. The international journal of biochemistry & cell biology. 66:45-58. 2015. Liu F, Wang B, Li L. Low-Dose Cadmium Upregulates VEGF Expression in Lung Adenocarcinoma Cells. International journal of environmental research and public health. 12(9):10508-21. 2015. Liu F, Zhang W, You X. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer. Oncotarget. 6(29):27199-213. 2015. Shan X, Wang D, Chen J. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer. Journal of computer assisted tomography. 37(1):22-8. 2013.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tusamitamab
Xentuzumab
E2F1 Antibody: E2F1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to E2F1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.
